Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:3755 (Glytoucan)

Id:f9753a52-5774-5258-8706-5ba881d95ec7

Glytoucan:G40027VO

Results found

Linked to

	Label	Description
	label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G59639BE-GLYCOSEQ00186049 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00004209 CUI has saccharide label:3755 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G90784AP-GLYCOSEQ00010769 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00028825 CUI has saccharide label:3755 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 has canonical residue n-glycan core b-d-manp c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G47279LF-GLYCOSEQ00181661 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G90784AP-GLYCOSEQ00010765 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G59639BE-GLYCOSEQ00186049 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00004209 CUI has saccharide label:3755

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G90784AP-GLYCOSEQ00010769 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00028825 CUI has saccharide label:3755

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 has canonical residue n-glycan core b-d-manp c

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G47279LF-GLYCOSEQ00181661 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3755 has glycosequence GLYGEN.GLYCOSEQUENCE:G90784AP-GLYCOSEQ00010765 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.